Skip to main content

Year: 2023

Probiotics in Animal Feed Market Forecast to 2026: Worth USD 6.24 Billion at a 7.30% CAGR

Probiotics in Animal Feed MarketProbiotics in Animal Feed MarketPune, India, Oct. 25, 2023 (GLOBE NEWSWIRE) — The global probiotics in animal feed market size is likely to benefit from the increasing awareness regarding animal health welfare. The market was valued at USD 3.56 Bn in 2018. Fortune Business Insights™ has predicted that the market will reach USD 6.24 Bn by 2026, thereby exhibiting a CAGR of 7.30%. Get a Sample Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/probiotics-in-animal-feed-market-101018 Some of the leading companies that are operating in the global probiotics in animal feed market are:Chr. Hansen A/S Danisco A/S Koninklijke DSM N.V. Lallemand Inc. Calpis Co Provita Eurotech Ltd Orffa International Holding B.V. BIOMIN Holding GmbH Novus International...

Continue reading

GCM Grosvenor to Announce Third Quarter 2023 Financial Results and Host Investor Conference Call on November 8, 2023

CHICAGO, Oct. 25, 2023 (GLOBE NEWSWIRE) — GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, announced today that it will release its results for the third quarter 2023 on Wednesday, November 8, 2023. Management will host a webcast and conference call on Wednesday, November 8, 2023 at 9:30 a.m. ET to discuss the results and provide a business update. The conference call will be available via public webcast through the Public Shareholders section of GCM Grosvenor’s website at www.gcmgrosvenor.com/public-shareholders and a replay will be available on the website soon after the call’s completion for at least seven (7) days. To register for the call, visit www.gcmgrosvenor.com/public-shareholders. About GCM Grosvenor GCM Grosvenor (Nasdaq: GCMG) is a global alternative asset management solutions...

Continue reading

PSB Holdings, Inc. Reports Third Quarter 2023 Earnings of $0.29 Per Share; Loan Growth Up 4.7% From Prior Quarter and 17.2% From Prior Year

WAUSAU, Wis., Oct. 25, 2023 (GLOBE NEWSWIRE) — PSB Holdings, Inc. (“PSB”) (OTCQX: PSBQ), the holding company for Peoples State Bank (“Peoples”) serving Northcentral and Southeastern Wisconsin reported third quarter earnings ending September 30, 2023 of $0.29 per common share on net income of $1.2 million, compared to $0.64 per common share on net income of $2.7 million during the second quarter ending June 30, 2023, and $0.80 per common share on net income of $3.5 million during the third quarter ending September 30, 2022. On July 5th, Wisconsin signed into law, and effective January 1, 2023, an interest exemption for financial institutions that lend to Wisconsin commercial borrowers. The change is expected to reduce or eliminate PSB’s state tax expense going forward. However, the current quarter includes cumulative adjustments...

Continue reading

Southern Michigan Bancorp, Inc. Announces Third Quarter 2023 Earnings

COLDWATER, Mich., Oct. 25, 2023 (GLOBE NEWSWIRE) — Southern Michigan Bancorp, Inc. (OTC Pink: SOMC) announced third quarter 2023 net income of $2,767,000, or $0.61 per share, compared to net income of $3,613,000, or $0.79 per share, for the third quarter of 2022. Southern earned $8,468,000, or $1.86 per share, for the nine-month period ending September 30, 2023 compared to $9,907,000, or $2.18 per share, for the same nine-month period a year ago. Consolidated assets at September 30, 2023 totaled $1.429 billion compared to $1.277 billion at December 31, 2022. Loan totals grew 17.1%, from December 31, 2022 levels of $886.6 million to $1.039 billion. Deposits totaled $1.192 billion at September 30, 2023, an increase of $101 million or 9.3%, as compared to year end 2022.   John Waldron, President and CEO of Southern Michigan Bancorp,...

Continue reading

Aquafeed Market Size to Reach USD 85.17 Billion by 2028 | 5.59% CAGR

Key segments covered in the aquafeed market report are By Type (Fish (Carps, Tilapias, Catfish, Salmons, and Others), Crustaceans, Mollusks, and Others), Ingredient (Soybean, Fishmeal, Fish Oil, Corn, Additives, and Others), Form (Dry and Wet), and Regional Forecast Report.Aquafeed MarketAquafeed MarketPune, India, Oct. 25, 2023 (GLOBE NEWSWIRE) — The global aquafeed market size is anticipated to reach USD 85.17 billion by 2028 and exhibit a CAGR of 5.59% during the forecast period. The increasing popularity of aquafeed and the rising investments in research and development activities are projected to foster growth in the market. The market’s growth is also ascribable to the increasing seafood trade due to the soaring seafood consumption and consumer expenditure on fish and fish products such as fish meal, fish oil, and...

Continue reading

Blue Foundry Bancorp Reports Third Quarter 2023 Results

RUTHERFORD, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) — Blue Foundry Bancorp (NASDAQ:BLFY) (the “Company”), the holding company for Blue Foundry Bank (the “Bank”), today reported a net loss of $1.4 million, or $0.06 per diluted common share, for the three months ended September 30, 2023, compared to net loss of $1.8 million, or $0.08 per diluted common share, for the three months ended June 30, 2023, and net income of $1.2 million for the three months ended September 30, 2022. James D. Nesci, President and Chief Executive Officer, commented, “Blue Foundry remains well capitalized with credit quality at historically stable levels. In addition to strong on-balance sheet liquidity, we have access to multiple sources of liquidity.” He continued, “We have also been pleased with the resourcefulness of our management team and employees in...

Continue reading

Rhythm Pharmaceuticals to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

BOSTON, Oct. 25, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, November 7, 2023 to report its third quarter 2023 financial results and provide a corporate update. To access the live conference call, participants may register here. While not required, it is recommended that participants join the call ten minutes prior to the scheduled start. Also today, Rhythm announced that David Meeker, M.D., Chair, President and Chief Executive Officer, will participate in a fireside chat at the Stifel Healthcare...

Continue reading

Alignment Healthcare Medicare Advantage Plan Named to U.S. News & World Report 2024 Best Insurance Companies for Medicare Advantage in North Carolina for Second Consecutive Year

Alignment’s North Carolina HMO achieved a 4.5- out of 5-star rating from the Centers for Medicare & Medicaid Services for 2024 RALEIGH, N.C. and ORANGE, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) — Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced that its North Carolina plan has been named a 2024 Best Insurance Company for Medicare Advantage (MA) in the state by U.S. News & World Report for the second consecutive year. Alignment Health Plan is one of only three MA plans in North Carolina to earn the U.S. News “Best” rankings badge. This recognition comes on the heels of Alignment’s North Carolina HMO achieving an overall 4.5- out of 5-star rating from the Centers for Medicare & Medicaid Services for 2024. Every year, Medicare evaluates plans based on a 5-star rating, which represents excellent performance. “We...

Continue reading

Aspira Women’s Health Sees Poster on its miRNA-based Ovarian Cancer Test Presented at the AACR Special Conference in Cancer Research

Data showed miRNA-protein models potential to improve the diagnostic accuracy of non-invasive ovarian cancer tests AUSTIN, Texas, Oct. 25, 2023 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gynecologic diseases today announced that a poster on an in-development miRNA-based ovarian cancer test was presented at the AACR Special Conference in Cancer Research: Ovarian Cancer, held on October 5, 2023 in Boston, MA. The test is expected to be launched as a part of the Company’s OvaSuite portfolio in collaboration with a consortium of world-renowned academic researchers under a previously announced licensing agreement. The poster, entitled: “Improving the diagnostic accuracy of an...

Continue reading

European Wax Center, Inc. to Report Third Quarter Fiscal 2023 Financial Results on November 8th

PLANO, Texas, Oct. 25, 2023 (GLOBE NEWSWIRE) — European Wax Center, Inc. (NASDAQ: EWCZ), the largest and fastest-growing franchisor and operator of out-of-home waxing services in the United States, today announced that it plans to report third quarter fiscal 2023 financial results before the market opens on Wednesday, November 8, 2023. Following the release, the company’s management will host a conference call at 8:00 a.m. ET/7:00 a.m. CT to review the results. To access the conference call dial-in information, analysts should click here to register online at least 15 minutes before the start of the call. All other participants are asked to access the earnings webcast at https://investors.waxcenter.com/. A replay of the webcast will be available two hours after the call and archived on the same web page for one year. About European...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.